Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimenrix vs Mencevax in adolescents
NCT00464815Phase 3Completed
- Sponsor
- GSK
- Start
- May 2007
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal infection, sponsored by GSK. Started May 2007; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00464815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464815.